ERBB2 and urothelial carcinoma: An analysis of HER2 status in molecular subtypes of 139 cases with urothelial carcinoma indicated 97 (65%) had IHC scores of 0 or 1+, 38 (26%) scored 2+, and 13 (9%) scored 3+ [33].